<p>(<b>A</b>) Schematic showing duration and frequency of pegylated-IFNα2a administration in participants. Transcript levels of (<b>B</b>) IFN-stimulated gene ISG15 and (<b>C</b>) A20 in PBMCs at baseline and after five weeks of IFNα treatment as assessed by qPCR. Statistical significance was determined by paired t-test. * P<0.05, ****P≤0.0001.</p
